Pages that link to "Q35219026"
Jump to navigation
Jump to search
The following pages link to Cancer vaccines: between the idea and the reality (Q35219026):
Displaying 50 items.
- B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma (Q24676809) (← links)
- Co-administration of a DNA vaccine encoding the prostate specific membrane antigen and CpG oligodeoxynucleotides suppresses tumor growth (Q24794166) (← links)
- Doxorubicin and paclitaxel enhance the antitumor efficacy of vaccines directed against HER 2/neu in a murine mammary carcinoma model (Q24805875) (← links)
- Reevaluation of the 22-1-1 antibody and its putative antigen, EBAG9/RCAS1, as a tumor marker (Q24814042) (← links)
- The Promise of Preventive Cancer Vaccines (Q26783742) (← links)
- Materials based tumor immunotherapy vaccines (Q26824135) (← links)
- Immunotherapy for prostate cancer: recent developments and future challenges (Q26852388) (← links)
- Anti-cancer vaccines - a one-hit wonder? (Q26995164) (← links)
- Role of α-gal epitope/anti-Gal antibody reaction in immunotherapy and its clinical application in pancreatic cancer (Q27024368) (← links)
- Design of universal cancer vaccines using natural tumor vessel-specific antigens (SANTAVAC) (Q28087470) (← links)
- Are oncoantigens suitable targets for anti-tumour therapy? (Q28240977) (← links)
- Vaccines for tumour prevention (Q28299036) (← links)
- Nanomaterials and autophagy: new insights in cancer treatment (Q28386642) (← links)
- Cancer immunotherapy via dendritic cells (Q29615444) (← links)
- Immunosuppressive networks in the tumour environment and their therapeutic relevance (Q29619244) (← links)
- Immunosuppressive strategies that are mediated by tumor cells (Q29636247) (← links)
- Age-dependent tolerance to an endogenous tumor-associated antigen (Q30439993) (← links)
- Radiation-induced tumor neoantigens: imaging and therapeutic implications (Q30473856) (← links)
- Crosstalk between PKA and Epac regulates the phenotypic maturation and function of human dendritic cells (Q30500371) (← links)
- Investigation of HIFU-induced anti-tumor immunity in a murine tumor model (Q30502120) (← links)
- An integrated approach of immunogenomics and bioinformatics to identify new Tumor Associated Antigens (TAA) for mammary cancer immunological prevention (Q33229377) (← links)
- Discovery of cancer vaccination protocols with a genetic algorithm driving an agent based simulator (Q33251199) (← links)
- Dynamics of central and peripheral immunomodulation in a murine glioma model (Q33410400) (← links)
- Myeloid-derived suppressor cells down-regulate L-selectin expression on CD4+ and CD8+ T cells (Q33567728) (← links)
- SANTAVAC ™: A Novel Universal Antigen Composition for Developing Cancer Vaccines (Q33578086) (← links)
- Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine (Q33584867) (← links)
- Increasing the antigenicity of synthetic tumor-associated carbohydrate antigens by targeting Toll-like receptors (Q33591916) (← links)
- CCL2 blockade augments cancer immunotherapy (Q33651427) (← links)
- B1 lymphocytes and myeloid dendritic cells in lymphoid organs are preferential extratumoral sites of parvovirus minute virus of mice prototype strain expression (Q33737706) (← links)
- Disruption of TGF-beta signaling prevents the generation of tumor-sensitized regulatory T cells and facilitates therapeutic antitumor immunity. (Q33772507) (← links)
- Limited transplantation of antigen-expressing hematopoietic stem cells induces long-lasting cytotoxic T cell responses (Q33838390) (← links)
- 4-1BB ligand as an effective multifunctional immunomodulator and antigen delivery vehicle for the development of therapeutic cancer vaccines (Q33857971) (← links)
- Immunotherapy of radioresistant mammary tumors with early metastasis using molecular chaperone vaccines combined with ionizing radiation (Q33859251) (← links)
- Laminarin promotes anti-cancer immunity by the maturation of dendritic cells (Q33888872) (← links)
- Long-term in vivo provision of antigen-specific T cell immunity by programming hematopoietic stem cells (Q33928413) (← links)
- Dendritic cell-regulatory T-cell interactions control self-directed immunity (Q34004810) (← links)
- Targeting the TLR9-MyD88 pathway in the regulation of adaptive immune responses (Q34048648) (← links)
- SA-4-1BBL as the immunomodulatory component of a HPV-16 E7 protein based vaccine shows robust therapeutic efficacy in a mouse cervical cancer model. (Q34065110) (← links)
- Different immunogenicity but similar antitumor efficacy of two DNA vaccines coding for an antigen secreted in different membrane vesicle-associated forms (Q34111151) (← links)
- Phase I clinical trial of the vaccination for the patients with metastatic melanoma using gp100-derived epitope peptide restricted to HLA-A*2402 (Q34173622) (← links)
- Vaccines for cancer prevention: a practical and feasible approach to the cancer epidemic (Q34180316) (← links)
- Therapeutic effects of autologous tumor-derived nanovesicles on melanoma growth and metastasis (Q34206187) (← links)
- Use of tumour-responsive T cells as cancer treatment (Q34285656) (← links)
- Designing Vaccines Based on Biology of Human Dendritic Cell Subsets (Q34289152) (← links)
- Cross-sectional and longitudinal analysis of cancer vaccination trials registered on the US Clinical Trials Database demonstrates paucity of immunological trial endpoints and decline in registration since 2008 (Q34306503) (← links)
- Tumor-induced endothelial cell surface heterogeneity directly affects endothelial cell escape from a cell-mediated immune response in vitro (Q34329922) (← links)
- Universal cancer vaccine: an update on the design of cancer vaccines generated from endothelial cells (Q34338192) (← links)
- T Cells and Stromal Fibroblasts in Human Tumor Microenvironments Represent Potential Therapeutic Targets (Q34343664) (← links)
- Interleukin-13 receptor α2 DNA prime boost vaccine induces tumor immunity in murine tumor models (Q34360520) (← links)
- Vaccines: past, present and future (Q34409178) (← links)